LISTEN TO THE Keynote Speakers
LISTEN FROM OUR CONFIRMED KEYNOTE SPEAKERS
Prof. Dr. Wolf-Henning Boehncke
Chair, Division of Dermatology, Geneva University Hospitals, Geneva
Prof. Dr. Wolf-Henning Boehncke
Chair, Division of Dermatology, Geneva University Hospitals, Geneva
Wolf-Henning Boehncke earned his M.D. as a fellow of the German Scholarship Foundation in Kiel and Glasgow, and received his postdoctoral training at the National Institutes of Health in Bethesda/USA. Following assignments at the University Hospitals in Kiel and Ulm he became Full Professor and Head of the Section of Allergy/Immunology at the Goethe-University in Frankfurt/Main. Since 2012, he is the Chairman of the Dermatology Unit at Geneva University. Prof. Boehncke currently serves as the president of SPIN (Skin Inflammation and Psoriasis International Network). He is also an active member and past president of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) and an active member of the International Psoriasis Council (IPC). His research focuses on the pathogenesis of inflammation on which he published more than 350 peer-review articles, among them landmark papers in the New England Journal of Medicine, The Lancet, Nature Medicine, and Nature, several of these were honoured by distinguished prizes.
Prof. Jose Carrascosa
Associate Professor Department of Dermatology, Universitary Hospital Germans Trias I Pujol, Badalona, Spain
Prof. Jose Carrascosa
Associate Professor Department of Dermatology, Universitary Hospital Germans Trias I Pujol, Badalona, Spain
José Manuel Carrascosa is Doctor in Medicine and Surgery at the Universitat Autònoma de Barcelona , he works as staff in the Dermatology Department of the Hospital Universitari Germans Trias I Pujol and has been Associate Professor since 2009. Dr Carrascosa has authored or co-authored 115 articles in dermatology journals in international journals, national magazines and book chapters. He is a member of the editorial board of Actas Dermo-sifiliográficas since 2005 and magazine ‘PIEL’ since 2008, editor-in-chief of Acta Dermo-sifiliográcias from 2010 to 2014 and reviewer of the journal Actas Dermosifiliográficas, Piel, Journal of Investigative Dermatology, British Journal of Dermatology, Journal of the European Academy of Dermatology and Venereology, Journal of Cellular Biochemistry and the Journal of Dermatology Science.
He has been chairperson or given invited lectures in 96 conferences, symposia and courses. He has acted as principal investigator or co-investigator in 22 clinical trials or funded projects related
to psoriasis, particularly in relation to new biological drugs. Dr Carrascosa is a member of the Academia Española de Dermatología y Venereología (AEDV), the European Academy of Dermatology and Venereology (EADV), the European Society of Contact Dermatitis, Colegio Ibero-Latino-Americano de Dermatología (CILAD) and the Acadèmia de Ciències Mèdiques de Catalunya i Balears.
Prof. Curdin Conrad
MD, Dermatology of Dermatology Functions, Head of Policlinics and the Center for Psoriasis, University Hospital of Lausanne, Switzerland
Prof. Curdin Conrad
MD, Dermatology of Dermatology Functions, Head of Policlinics and the Center for Psoriasis, University Hospital of Lausanne, Switzerland
Dr. Curdin Conrad is a Professor of Dermatology and head of policlinic and the center for psoriasis at Lausanne University Hospital in Switzerland. He received his MD training at the University of Zurich and participated in the Postgraduate Course of Experimental Medicine and Biology. After training in dermatology, he was a research fellow at MD Anderson Cancer Center in Houston, Texas.
Dr. Conrad has a strong interest in inflammatory skin diseases, adaptive and innate immunity, and targeted immunotherapies, from basic science to translational research and the clinic. He has fundamentally contributed to today’s understanding of the pathogenesis of psoriasis and has received several scientific awards for his basic and translational research. Over the years, Dr. Conrad has actively been involved in the teaching of evidence-based clinical and scientific dermatology and immunology.
He serves as an external scientific expert for several international societies and foundations. Dr. Conrad is an elected Councilor of the International Psoriasis Council (IPC) and a Board Member of the European Society for Dermatological Research (ESDR).
Prof. Carsten Flohr
Chair in dermatology and population science, St John’s Institute of Dermatology, King’s college London, UK
Prof. Carsten Flohr
Chair in dermatology and population science, St John’s Institute of Dermatology, King’s college London, UK
Carsten Flohr studied at Cambridge and Oxford Universities and then trained in both paediatrics and dermatology. He was the first uk national institute for health research (nihr) clinician scientist in dermatology (2009-2014) and currently holds a senior career development fellowship from the nihr. He directs the unit for population-based dermatology research at st John’s Institute of Dermatology and is also consultant dermatologist and research & development lead at st John’s Institute of Dermatology, guy’s & st thomas’ nhs foundation trust, London, UK.
Prof Flohr has a particular interest in population-based dermatology research and clinical trials with a focus on atopic eczema. For instance, he is chief investigator of the uk-irish treatment of severe eczema in children trial (treat), which compares ciclosporine with methotrexate in children with recalcitrant atopic eczema. He is also chief investigator of the uk-irish atopic eczema systemic therapy register (a*star).
He is editor of the evidence-based dermatology section of the _british journal of dermatology_ and the clinical trials editor of the _f1000_atopic dermatitis section.
Prof. Amit Garg
Professor and Founding Chairman for the Department of Dermatology at the Zucker School of Medicine at Hofstra Northwell in New York City, USA
Prof. Amit Garg
Professor and Founding Chairman for the Department of Dermatology at the Zucker School of Medicine at Hofstra Northwell in New York City, USA
Dr. Garg is Professor and Founding Chairman for the Department of Dermatology at the Zucker School of Medicine at Hofstra Northwell. He is also Professor in the Center for Health Innovation and Outcomes Research at the Feinstein Institutes for Medical Research. Dr. Garg currently serves as the President for the Northwell Health Physician Partners, a medical group representing over 6000 doctors at Northwell Health in New York.
Dr. Garg’s subspecialty expertise is interdisciplinary based in caring for patients with autoimmune and inflammatory conditions including hidradenitis suppurativa and psoriasis. Dr. Garg's funded research interests include identification of comorbidities using ‘Big Data’, and development of a core outcome set for clinical trials for dermatologic diseases.
Dr. Garg is Chair of the Council on Education for the American Academy of Dermatology. He has held leadership roles within national professional organizations, including C3 (CHORD
COUSIN Collaboration), HiSTORIC (Hidradenitis Suppurativa Core Outcome Set International Collaboration), Hidradenitis Suppurativa Foundation, the Group for Research and Assessment of
Psoriasis and Psoriatic Arthritis, the National Psoriasis Foundation, the Association of Professors of Dermatology, the Medical Dermatological Society, and the American Academy of
Dermatology. Dr. Garg recently served as Vice Chair for the Dermatology's Residency Review Committee of the Accreditation Counsel of Graduate Medical Education (ACGME).
Dr. Garg serves on the editorial board for the Journal of the American Academy of Dermatology and he is the Outcomes section editor for the journal Dermatology. He has published a number of articles in the peer-reviewed literature and has authored several book chapters. Dr. Garg was awarded the 2016 Thomas G. Pearson, EdD Memorial Education Award by the American Academy of Dermatology.
Dr Louise Gerbens
MD PhD, Dermatologist at Huid Medisch Centrum & Amsterdam UMC
Dr Louise Gerbens
MD PhD, Dermatologist at Huid Medisch Centrum & Amsterdam UMC
Louise Gerbens obtained her medical degree at the University of Amsterdam and via the U.S. Educational Commission for Foreign Medical Graduates (ECFMG) certification. She is currently a resident in Dermatology at the Amsterdam University Medical Centers, expecting to complete her training in June 2021. She holds a PhD in Dermatology from the University of Amsterdam (2018), for which she investigated measurement instruments, datasets and systemic therapies for atopic eczema (pure.uva.nl/ws/files/22834815/Thesis.pdf). During her PhD, she became member of the Harmonising Outcome Measures for Eczema (HOME) initiative, for which she co-led the symptoms domain, and continues to serve as a board member. She also co-initiated the international (and Dutch) TREatment of ATopic eczema (TREAT) Registry Taskforce (treat-registry-taskforce.org, treatregister.nl), which is currently collecting data and has collaborators from 10 different countries.
Prof. Michel Gilliet
MD, Chair of the Department of Dermatology at the University Hospital CHUV in Lausanne, Switzerland.
Prof. Michel Gilliet
MD, Chair of the Department of Dermatology at the University Hospital CHUV in Lausanne, Switzerland.
Michel Gilliet, M.D. is Chair of the Department of Dermatology at the University Hospital CHUV in Lausanne, Switzerland. He received his training in Dermatology at the University of Zürich, Switzerland and his research training in Immunology at the DNAX Research Institute in Palo Alto, California. In 2004, he was recruited to the MD Anderson Cancer Center in Houston, Texas, first as Assistant Professor, then as tenured Associate Professor with a clinical appointment in Dermatology, a translational research appointment in Melanoma Oncology, and a basic science appointment in Immunology. In 2010 he returned to Switzerland as Full Professor and Chair of the Department of Dermatology in Lausanne.
His research has focused primarily on translational research studying immune responses in inflammatory skin diseases and melanoma. In particular, his lab has discovered mechanisms how dendritic cells initiate and drive inflammation in the skin based the complex formation of DNA with antimicrobial peptides. These studies provided a paradigm shift in the understanding how inflammation is regulated in wounded skin and inflammatory diseases such as psoriasis and lupus erythematosus. Dr Gilliet has also been involved in the initial discovery of TSLP and its role in driving allergic inflammation in atopic dermatitis. These studies have resulted in more than 100 peer-reviewed publications with over 19,000 citations, including papers published in Nature, Nature Immunology, Nature Medicine, Nature. Dr. Gilliet has served as Secretary Treasurer (2016-17) and President (2018) of the European Society of Dermatological Research (ESDR) and is honorary member of several international associations including Austria, France and Japan. In 2016, he has received the Cloetta Prize, the most prestigious Award for Medical Research in Switzerland.
Prof. Emma Guttman
MD, PhD, Professor of Dermatology and Immunology at the Icahn School of Medicine at Mount Sinai in New York City, USA
Prof. Emma Guttman
MD, PhD, Professor of Dermatology and Immunology at the Icahn School of Medicine at Mount Sinai in New York City, USA
Emma Guttman-Yassky, MD, PhD is the Waldman Professor of Dermatology and Immunology and the health system chair of the department of dermatology at the Icahn School of Medicine at Mount Sinai, New York. She is also the director of the center for excellence in eczema and the laboratory for inflammatory skin diseases. She earned her M.D. from Sackler School of Medicine at the Tel-Aviv University, and a Ph.D. degree from the Bar-Ilan University, Israel. After her first Board certification in dermatology in Israel, Dr. Guttman moved to the U.S. to pursue a two-year postdoctoral fellowship at The Rockefeller University in the Laboratory for Investigative Dermatology. Upon completion of her fellowship, she became board-certified by the American Board of dermatology, after completing a second dermatology residency training at Weill-Cornell Medical College, in NY. Dr. Guttman’s major research focus areas are atopic dermatitis (AD)/eczema and hair loss disorders. Her research made paradigm-shifting discoveries on the immunologic basis of AD/eczema in adults and children with atopic dermatitis, enriching the understanding of the pathophysiology of this common disorder, opening the door for novel, pathway-specific drugs in this disease. Recently, Dr. Guttman extended her research interest to hair loss disorders such as alopecia areata and scarring hair loss disorders, chronic hand eczema, keloids, ichthyosis, and other skin diseases, in which her findings are also translated to novel therapeutics. She has recently made paradigm changing discoveries linking alopecia areata to the atopic/allergic march, with therapeutic implications. Dr. Guttman
co-founded the international eczema council (IEC) and is its immediate past president.
Dr. Guttman received many national and international awards (e.g the AAAAI Award for Scientific Innovation and for pioneering discoveries, AAD Young Investigator award, etc). She was elected as a member to the American Society for Clinical Investigation/ASCI, and the American Dermatological Society/ADA. She is a cofounder and organizer of one of the most important global meetings in dermatology, the Inflammatory Skin Disease Summit (ISDS), and serves on the editorial board of several high impact journals. Dr. Gutman delivered many keynote and plenary presentations in international and national meetings and authored >370 peer-reviewed
publications.
Prof. Barbara Horvath
MD, Phd, Chairman of the Department of Dermatology, University Medical Center Groningen, The Netherlands
Prof. Barbara Horvath
MD, Phd, Chairman of the Department of Dermatology, University Medical Center Groningen, The Netherlands
Dr. Barbara Horvath is Professor and since 2019 Chairman of the Department of Dermatology and the Expertise Center for Blistering Diseases, an ERN-labeled national expertise center at the University Medical Center Groningen at the Netherlands. She was trained at the Semmelweis University in Budapest, Hungary. She did her PhD studies at the Department of Genetics, Cell- and Immunobiology at the Semmelweis University in Budapest. After her doctoral thesis she followed residency in dermatology at the Department of Dermatology and skin-oncology at the Semmelweis University. Since 2008 she is a staff member at the department of dermatology at the University Medical Center of Groningen (UMCG). Between 2012-2021 she was the head of national residency
training program in dermatology in the Netherlands. Her main expertise and research interest is hidradenitis suppurativa, autoimmune blistering diseases.
Barbara Horvath is a member of the EADV taskforce on Acne, Hidradenitis suppurativa and Rosacea and on Autoimmune Blistering Diseases. She is board member of the European Reference Network on rare diseases. Barbara Horvath is associate editor of the British Journal of Dermatology, Editor of the textbook Autoimmune Bullous disease, author of several book chapters and peer reviewed articles.
Prof. Kenji Kabashima
Chairman and Head, Department of Dermatology, Kyoto University Graduate School of Medicine, Japan
Prof. Kenji Kabashima
Chairman and Head, Department of Dermatology, Kyoto University Graduate School of Medicine, Japan
Dr. Kabashima graduated from Kyoto University in 1996. He started research on bioactive lipid mediators at Kyoto University, which led to a PhD. Currently, he is a chair/professor at the Department of Dermatology, Kyoto University Graduate School of Medicine, Japan, a principal investigator at the SRIS/SIgN, Singapore, and visiting consultant at the National Skin Centre, Singapore. His main interests include the mechanism of inflammatory skin diseases and 3D-visualization of the skin using two-photon microscopy (Publications, >500, h-index 59 by google
scholar). His hobbies are running and travelling.
Associate Prof. Brett King
Associate Professor of Dermatology, Yale School of Medicine at Middlebury, USA
Associate Prof. Brett King
Associate Professor of Dermatology, Yale School of Medicine at Middlebury, USA
Brett King specializes in inflammatory skin diseases – in particular alopecia areata, vitiligo and atopic dermatitis – as well as hair loss disorders. He pioneered the use of Janus kinase (JAK) inhibitors in dermatology, and his work has revealed the broad utility of JAK inhibitors for the treatment of alopecia areata, vitiligo, atopic dermatitis, granulomatous diseases, as well as other conditions.
Prof. Antonios Kolios
Associate Professor in The Immuno-Dermatology unit in the Department of Dermatology, University Hospital Zurich, Switzerland
Prof. Antonios Kolios
Associate Professor in The Immuno-Dermatology unit in the Department of Dermatology, University Hospital Zurich, Switzerland
Antonios Kolios (born 1983) is physician scientist, trained in Dermatology and Venerology as well as Clinical Immunology and Allergology, currently running as senior attending physician the immuno-dermatology unit in the Department of Dermatology, University Hospital Zurich, Switzerland, where he is responsible for all inflammatory skin diseases incl. psoriasis, hidradenitis suppurativa, lupus, vitiligo, pityriasis rubra pilaris and others.
From 2020 until 2021 he was at the Beth Israel Deaconess Medical Center (BIDMC) / Harvard Medical School in Boston, MA in the Department of Rheumatology and Clinical Immunology with Prof. George Tsokos, an international renown expert in Systemic Lupus Erythematosus. During that time, he received his habilitation as Privatdozent (PD, corresponding to Assistant Professor) at the University of Zurich (UZH) in Switzerland, where he is also running his own group and is giving student lectures and
courses.
His research is focused on restoration of immune balance in autoimmune skin diseases incl. psoriasis, vitiligo and cutaneous lupus as well as identification of pathogenetic investigation with possible translation into treatment approaches in inflammatory skin diseases. Currently one promising drug candidate is in a clinical translational program. Also, he is national principal investigator for the Swiss hidradenitis suppurativa registry. He received several grants, awards and authored over 65 publications on immune-mediated skin disorders in journals like New England Journal of Medicine, Nature Review Rheumatology, Science Immunology, Lancet Rheumatology, Journal of Investigative Dermatology, British Journal of Dermatology, JAMA Dermatology and others.
His enthusiasm in Immuno-Dermatology is driven by his curiosity of translating basic research in inflammatory skin diseases into targeted, patient-tailored treatment strategies.
Prof. James Krueger
MD, PhD, Head of the Laboratory for Investigative Dermatology at The Rockefeller University in New York City, USA
Prof. James Krueger
MD, PhD, Head of the Laboratory for Investigative Dermatology at The Rockefeller University in New York City, USA
Dr. Krueger is head of the Laboratory for Investigative Dermatology at The Rockefeller University in New York City. He also serves as a physician and codirector for the Center for Clinical and Translational Science at The Rockefeller University Hospital in New York as well as chief executive officer of the hospital. He earned his bachelor’s degree from Princeton University and a Ph.D. in virology and cell biology from The Rockefeller University. He received his M.D. from Cornell University Medical College, where he also completed an internship in internal medicine and residency in dermatology. Dr. Krueger is certified by the American Board of Dermatology. His research group at Rockefeller was the first to conduct clinical trials with specific, targeted immune antagonists in psoriasis; this work established that elimination of pathogenic T cells from skin lesions could reverse the full pathological phenotype of psoriasis. Since then, his group has used immune-based therapeutics to dissect inflammatory pathways in psoriasis and to conduct parallel pharmacogenomic studies that define mechanisms of targeted therapeutics in human populations. A more recent focus has been definition of new inflammatory pathways as well as new types of inflammatory cells in psoriasis lesions that are now being targeted with new biologic drugs.
Prof. Jo Lambert
Chair Department of Dermatology, Ghent University Hospital, Belgium
Prof. Jo Lambert
Chair Department of Dermatology, Ghent University Hospital, Belgium
Passionate doctor and researcher with extensive experience in (academic) healthcare hospital settings. Adept in properly diagnosing and strategizing for innovation in healthcare. Bringing forth an empathetic and professional attitude, committed to providing patients with the best care possible, fueled by research. Experienced in institutional leadership working well under pressure and with other professionals.
Prof. Jörg Prinz
Univ.-Prof. Dr. med. Univ. Jörg Christoph PRINZ, Clinic for Dermatology and Allergology, Ludwig-Maximilians-University, Munich, Germany
Prof. Jörg Prinz
Univ.-Prof. Dr. med. Univ. Jörg Christoph PRINZ, Clinic for Dermatology and Allergology, Ludwig-Maximilians-University, Munich, Germany
Jörg Prinz holds a permanent Professorship for Dermatology and Venerology at the Clinic for Dermatology and Allergology, Ludwig-Maximilians-University, Munich.
He is responsible for the phototherapy unit and psoriasis centre and the serological analysis laboratory at the clinic. Having obtained his medical degree in 1983, Prof. Prinz worked as a post doctoral researcher at the Department of Immunology, Ludwig-Maximilians-University Munich until 1990. Since 1990, he has been a physician at the university, where he established and continues to manage the Research Group for Immunopathology. Prof. Prinz went on to attain his specialist qualifications in dermatology and venerology in 1995, and allergology in 1996. His main research interest is the analysis of the T-cell mediated immunopathogenesis of psoriasis and the identification of psoriatic autoantigens. Prof. Prinz is also interested in developing experimental therapies for T-cell mediated autoimmune disorders, and has been actively involved in preparing evidence-based guidelines for psoriasis treatment.
Prof. Lluis Puig
MD, PhD, Chair, Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Professor of Dermatology at Universitat Autònoma de Barcelona, Barcelona, Spain
Prof. Lluis Puig
MD, PhD, Chair, Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Professor of Dermatology at Universitat Autònoma de Barcelona, Barcelona, Spain
Prof. Julien Seneschal
Professor of Dermatology at the Department of Dermatology, National Reference Center for Rare Skin Diseases, University of Bordeaux
Prof. Julien Seneschal
Professor of Dermatology at the Department of Dermatology, National Reference Center for Rare Skin Diseases, University of Bordeaux
Dr Julien Seneschal is Professor of Dermatology at the Department of Dermatology, National Reference Center for Rare Skin Diseases, University of Bordeaux. He is the head of the Inflammatory and Auto-Immune Skin Disorders Unit and is responsible for the Vitiligo and Pigmentary disorders clinic and is leader of the immune-dermatology research team at INSERM U1035 unit, University of Bordeaux. He completed his internship at the University of Bordeaux and was a research fellow at Harvard University, Department of Dermatology under the guidance of Professor Thomas S. Kupper.
Dr Seneschal’s research is focusing on the understanding of the immune pathogenesis of inflammatory skin disorders with a special interest in vitiligo. His team projects explore the phenotype and function of resident memory T cells in vitiligo and the impact of pro-inflammatory cytokines on melanocytes function, survival and adhesion. This translational research aims to identify novel therapeutic approaches.
He is authors of several clinical and research articles related to skin inflammatory diseases published in the Journal of Investigative Dermatology, Science Translational Medicine, Immunity. He is board member of the European Society for Dermatological Research (ESDR) and president of the French Society for Research in Dermatology. He received awards from the French Society for research in dermatology, the Roche Posay European Foundation award and the Charles Grupper (Leo Pharma) award.
Prof. Phyllis Spuls
MD, Phd, Consultant Dermatologist at The Academic Medical Centre of the University of Amsterdam, The Netherlands
Prof. Phyllis Spuls
MD, Phd, Consultant Dermatologist at The Academic Medical Centre of the University of Amsterdam, The Netherlands
Professor of Evidence Based Dermatology, MD, Phd, and Consultant Dermatologist at The Amsterdam University Medical Centers, location Academic Medical Centre, of the University of Amsterdam, The Netherlands
She qualified in medicine from the University of Amsterdam Medical School. She worked for 4 years as fellow dermatologist at the Mount Sinai School of Medicine in New York and for 3 years at the Dutch Cochrane Centre.
Prof Spuls has a lot of experience in both clinical practice, education, and research in dermatology. She is a passionate doctor and researcher with a focus on the old and new treatments of psoriasis and eczema. She is interested in developing core outcome sets (see Chord Cousin Collaboration) and guidelines in the field of dermatology, in performing investigator initiated clinical trials and systematic reviews, and collect clinical data in registries (see TREAT Registry Taskforce) to improve the care for patients with dermatoses in many ways.
Prof. Michael Simpson
Head of the Department of Medical and Molecular Genetics at King’s College London, United Kingdom
Prof. Michael Simpson
Head of the Department of Medical and Molecular Genetics at King’s College London, United Kingdom
Professor Michael Simpson is the Professor of Genetics and Head of the Department of Medical and Molecular Genetics at King’s College London. He has a specific research interest in the genetics of inflammatory skin disease and has led a series of large-scale studies of the genetic predisposition to psoriasis and acne, which have provided critical insight into disease mechanisms.
Michael originally trained as a pharmacologist and subsequently studied Human Molecular Genetics at Imperial College before undertaking his PhD at St. George’s University of London. His doctoral research focused on resolving the genetic basis of recessive disorders found at an elevated frequency in Old Order Amish populations. In 2009, Michael moved to King’s College London, where his research capitalized on advances in DNA sequencing technologies to identify the genetic basis of a series of rare diseases, including pustular psoriasis that had proved intractable to traditional gene mapping approaches.
His research group continues to focus on understanding the molecular and cellular mechanisms of the genetic susceptibility to skin disease and the genetic basis of variation in therapeutic. Michael is also actively involved in developing the analytical approaches needed to deploy contemporary genomic technologies at scale in healthcare systems.
Prof. Tiago Torres
Professor of Dermatology at the Instituto de Ciências Biomédicas Abel Salazar, University of Porto, Portugal
Prof. Tiago Torres
Professor of Dermatology at the Instituto de Ciências Biomédicas Abel Salazar, University of Porto, Portugal
Tiago Torres is Professor of Dermatology at the Instituto de Ciências Biomédicas Abel Salazar, University of Porto. He received his medical degree from the Faculdade de Medicina, University of Porto, completed a residency program in Dermatology and Venereology at Centro Hospitalar Universitário do Porto (CHUP) and finished his PhD thesis in 2014 studying the role of psoriasis- associated systemic inflammation in atherosclerosis.
Currently, he is the Head of the Immunodermatology Unit (psoriasis, atopic dermatitis and auto-immune diseases) and Clinical Trials Unit of the Department of Dermatology of CHUP. Through the years has been principal investigator for several psoriasis and atopic dermatitis clinical trials.
Tiago Torres has been involved in the development of national guidelines for the treatment of psoriasis, has received the “Juvenal Esteves” Prize from the Portuguese Society of Dermatology and Venerology with research projects in psoriasis and psoriatic arthritis in 2011, 2013, 2017 and 2018, as well as two grants for atopic dermatitis projects in 2018. Serves as Associate Editor of Acta Médica Portuguesa, Journal of the Portuguese Society of Dermatology and Venerology and Drugs in Context and belongs to the editorial board of Drugs and the Foundation René Touraine’s Book “Therapeutics In Dermatology”.
Currently, Tiago Torres is the President of the Portuguese Group of Psoriasis and an International Psoriasis Council member. Tiago Torres has published many articles on psoriasis and atopic dermatitis and has been the editor of the Portuguese book “Psoriasis and Psoriatic Arthritis”. His main research topics in dermatology are immunodermatology, immunology and immunopharmacology of psoriasis and atopic dermatitis.
Prof. Christian Vestergaard
Clinical professor and chair in dermato-venerology at the Department of Clinical Medicine at Aarhus University and the Department of Dermatology at Aarhus University Hospital, Denmark
Prof. Christian Vestergaard
Clinical professor and chair in dermato-venerology at the Department of Clinical Medicine at Aarhus University and the Department of Dermatology at Aarhus University Hospital, Denmark
Dr. Christian Vestergaard graduated from Aarhus University in 1998, after which he started his studies in Atopic Dermatitis and inflammation as a Monbusho Scholar at the University of Tokyo. Dr. Vestergaard completed the studies as part of his ph.d. in the Dermatological research laboratory at the Department of Dermatology, Aarhus University Hospital. After achieving the ph.d. degree he was awarded a two year postdoctoral position from the Danish National Research council, which lead to the completion of the Danish Doctoral thesis with focus on inflammation Dr. Vestergaards research still has focus on the inflammatory reaction in the skin and it’s influence on skin-barrier function, but also on the epidemiology of co-morbidities
in atopic dermatitis. Dr. Vestergaards research group also focuses on bullous pemphigoid, mastocytosis, and skin changes of malnutrition with phd students, MD student and master of science students.
Dr. Vestergaard achieved his board certification in Dermatology after training at the Departments of Dermatology in Aarhus and Odense. He is now an associate professor at the Department of Dermatology Aarhus University and National Director of The Training in Dermatology in Denmark. Dr Vestergaard has for the last 6 years been the daily leader of the urticaria clinic, and been an active teacher at the eczema school for Atopic Dermatitis patients and their parents in Aarhus. He serves as chairman of the Danish Dermatological Society. He also serves as member of the editorial board of JEADV, and as an international advisory board of the Journal of Dermatology, and is associate section editor at the British Journal of Dermatology.
Dr. Dmitri Wall
MD, Consultant Dermatologist
Dr. Dmitri Wall
MD, Consultant Dermatologist
Dr. Dmitri Wall is a consultant Dermatologist with a special interest in hair disorders. A graduate of University College Dublin, Ireland, he completed higher specialist training with the Royal College of Physicians of Ireland before undertaking an international hair fellowship in Melbourne, Australia with Professor Rodney Sinclair. Since his return in 2019, he has worked as a consultant in St James’s Hospital, Dublin, Ireland, and Hair Restoration Blackrock, Dublin, Ireland.
Dr. Wall also has a special interest in health informatics. He has obtained an MSc through Trinity College Dublin, Ireland, and has worked with Professor Alan Irvine and the Irish Skin Foundation charity, over the last decade, to develop the not-for-profit company National and International Skin Registries (NISR), that develops international patient registries. Dr. Wall has combined interests in hair and health informatics to lead development, along with colleagues in Australia – Rodney Sinclair, Bevin Bhoyrul; the U.K. – Nekma Meah; and South Africa – Katherine York, of a global network of patient registries for alopecia areata with a view to improving international collaboration and facilitating re-use of comparable clinical data.
Most recently Dr. Wall has worked with colleagues internationally to establish two global, physician-entered, anonymized patient registries, SECURE-AD (Alan Irvine – Ireland, Carsten Flohr – United Kingdom, Phyllis Spuls, Annelie Musters, Angela Bosma – The Netherlands) and SECURE-Alopecia (Rodney Sinclair, the U.K. – Nekma Meah; and South Africa – Katherine York; Ireland – Alan Irvine), to record and analyze outcomes of COVID-19 positive patients suffering from atopic dermatitis and all forms of alopecia, respectively.
Prof. Christos Zouboulis
Director of the Departments of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, Germany
Prof. Christos Zouboulis
Director of the Departments of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, Germany
Prof. Dr. med. Prof. honoraire Dr. h.c. Christos C. Zouboulis is full Professor of Dermatology, Venereology and Allergology at the Brandenburg Medical School Theodor Fontane and the Faculty of Health Sciences Brandenburg and Director of the Departments of Dermatology, Venereology, Allergology and Immunology, Staedtisches Klinikum Dessau, Dessau, Germany. He is also Professeur honoraire at the Medical Faculty, University of Franche-Comté, Besançon, France and Dr. h.c. of the National and Kapodistrias University of Athens, Greece.
Prof. Zouboulis has studied medicine and political sciences at the National and Kapodistrian University of Athens, Greece. He performed pre-doctoral work on cell biology at the Department of Dermatology, Benjamin Franklin Medical Center, Freie Universitaet Berlin, Germany where he was awarded his thesis title (Dr. med.) in 1988. He further continued his postgraduate medical education and completed the residencies in Dermatology and Venereology as well as in Allergology at the same department. Subsequently, he joined the Department of Dermatology, University of Michigan Medical Center, Ann Arbor, MI, USA for a research fellowship on molecular biology, and the Department of Dermatology, Cleveland Clinic Foundation, Cleveland, OH, USA as well as the Department of Dermatology, Massachusetts General Hospital, Harvard University, Boston, MA, USA for clinical research before returning as faculty member at the Department of Dermatology, Freie Universitaet Berlin, where he accomplished his habilitation thesis (Priv.-Doz.) in 1995. In 2000, he was named Professor of Dermatology and Venereology of the Freie Universitaet Berlin, where he served as Vice Chair of the Department of Dermatology from 2000 to 2005. In 2005 he was elected Director of the Departments of Dermatology, Venereology, Allergology and Immunology at the Staedtisches Klinikum Dessau, Dessau, Germany, in 2016 Founding Professor of Dermatology and Venereology at the Brandenburg Medical School Theodor Fontane, Germany and in 2019 co-opted Professor of Dermatology, at the Faculty of Health Sciences Brandeburg.
Prof. Zouboulis is President of the European Hidradenitis Suppurativa Foundation e.V., the German Registry Adamantiades-Behçet Disease e.V., the Berlin Foundation of Dermatology and the Section Saxony-Anhalt of the Federation of German Allergologists; Honorary President of the European Society of Preventive, Regenerative and Anti-Aging Medicine (ESAAM), Executive Committee Member of the International Society on Behçet’s Disease, Board Member of the European Reference Network of Rare and Complex Skin Diseases, coordinator of the European Academy of Dermatology and Venereology (EADV) Task Force on Acne, Rosacea and Hidradenitis Suppurativa. He is Editor of the European Academy of Dermatology and Venereology (EADV) News, Co-Editor of Rejuvenation Research and serves in the Editorial Boards of several leading international scientific journals.
He has received numerous awards for his scientific work, including the EADV Research Fellowship, the Oskar Gans Major Prize of the German Dermatological Society, the Nékám Award of the Hungarian Dermatological Society, the Felix Wankel Animal Protection Research Prize, the Gerson Unna Prize on Immunology, the Skin Cancer Prize, the “Beauty Care Prize” for Dermatological Research, the "Germany land of ideas - 2009 place of excellence" for Skin Stem Cell Research, the “Geroulanos Prize” for History of Medicine, the Paul “Liérac Research Award” for Skin Aging Research, the Springer Prize for Dermatology, the Open Health Alliance Excellence Award, and the Honorary Membership of the Patients` Charity „Deutsche Interessengemeinschaft Akne inversa e.V.“)
Prof. Zouboulis was elected Prof. honoraire of the University of Franche-Comté, Besançon, France, Dr. h.c. of the National Kapodistria University of Athens, Visiting Professor of the Jiao Tong University of Shanghai, China and European Union Teaching Professor at the Europa University of Kaunas, Lithuania. He has received the silver medal (highest academic recognition) of the Wroclaw University, Wroclaw, Poland, the Medal of the Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel and is honorary member of the French, the Hungarian, the Italian, the Lithuanian, the Maltese and the Portuguese Dermatological Societies.
Prof. Zouboulis has performed fundamental research - among other fields - on Dermato-Endocrinology and sebaceous glands, acne, hidradenitis suppurativa/acne inversa, skin stem cells, molecular ageing, dermato-pharmacology, cryosurgery, and rare diseases including Adamantiades-Behçet disease. He is the author of more than 1150 publications (cumulative impact factor >3300; h index 117, citations >54,000), has given over 1000 invited lectures, has organized numerous conferences and is owner of six patents, including one for the SZ95 sebaceous gland cell line, an in vitro model for acne, aging and lipid research. He has first described the flashing pulsating angioma and the trias of keratosis pilaris, ulerythema ophryogenes and 18p monosomy, whereas the latter has been confirmed by several other authors and has been proposed as Zouboulis syndrome.
